logo-loader
viewEquiniti

Equiniti shares jump as it expects full-year earnings to reach top end of market forecasts

Equiniti said revenues were boosted by contract renewals and new client wins

finance
Equiniti bought the Wells Fargo's share registration business in February

Equiniti Group PLC (LON:EQN) shares jumped as the technology outsourcer said it expects full-year earnings to meet the top end of market expectations after delivering a stronger-than-expected first half.

In the six months ended June 30, underlying earnings (EBITDA) shot up 31.6% to £55mln and revenue increased 30.4% to £254mln, both ahead of expectations.

Organic revenue rose 7.7%, boosted by contract renewals and new client wins.

READ: Equiniti says 2018 has started well

Contract renewals included UK registration clients Carnival PLC (LON:CCL), easyJet PLC (LON:EZY), GlaxoSmithKline plc (LON:GSK) and Prudential PLC (LON:PRU).

The firm won new clients across all divisions, including CNPP, Persimmon and Ulster Bank.

In the UK, the company increased its market share as it secured business wins including Bodycote PLC (LON:BOY), Hiscox PLC (LON:HSX), and Low & Bonar PLC (LON:LWB).

In the US, the group secured contract renewals with CVS, General Electric, JP Morgan, 3M and MDU.

Around 70% of newly listed companies signed up to take Equiniti's services including Acacia Pharma, Avast, IntegraFin Holdings and KRM 22.

Equiniti buys Wells Fargo's share registration business and Boudicca Proxy

Equiniti expanded the business during the period with two acquisitions.

In February, the company completed the acquisition of Wells Fargo's share registration business for US$227.0mln. In April, it bought Boudicca Proxy Limited, which specialises in proxy solicitation, shareholder communications, corporate governance advisory and share ownership.

"The first half of 2018 has been our strongest reporting period yet, with accelerating organic growth supplemented by the successful completion of the high-quality Shareowner Services business from Wells Fargo Bank,” said chief executive Guy Wakeley.

“Our UK business remains the undisputed market leader for registration and share plans, with more new clients choosing Equiniti. The deployment of these core capabilities into the US, along with proprietary technologies for payments, pensions, credit and analytics, creates multiple opportunities for future growth.”

Full-year earnings to reach top end of forecasts

The group expects to reach the upper end of analysts’ forecasts for underlying EBITDA of £116.0mln to £122.9mln.

The interim dividend was lifted 11.6% to 1.83p.

Wakeley added: "We continue to make good progress against our long-term strategy with sustainable organic growth, progressive margin and dividend expansion, and the utilisation of strong cash flow to invest in new capabilities whilst strengthening the balance sheet.  We remain committed to disciplined capital allocation into our best-performing assets to sustain continued earnings growth”. 

Shares gained 12.5% to 234p in morning trading. 

Quick facts: Equiniti

Price: 196.9 GBX

LSE:EQN
Market: LSE
Market Cap: £717.77 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...

14 hours, 49 minutes ago

RNS

Director/PDMR Shareholding

16 hours, 37 minutes ago

TRADING UPDATE

23 hours, 22 minutes ago

Director/PDMR Shareholding

1 week, 6 days ago

Total Voting Rights

2 weeks, 5 days ago

Director/PDMR Shareholding

3 weeks, 1 day ago

3 min read